Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 454 | $432 K | $951.26 | Jan 2, 2024 | Direct |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Common Stock | 1,467 | $335 K | $228.41 | May 13, 2024 | Direct |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Stock Options (Right to Buy) | 1,311 | $299 K | $228.41 | May 13, 2024 | Direct |
REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 1,607 | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | May 13, 2024 | 2 | 427,127 | 4 | May 15, 2024 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 2, 2024 | 2 | 0 | 4 | Jan 4, 2024 | Director |
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | May 15, 2023 | 2 | 321,049 | 4 | May 17, 2023 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Jan 3, 2023 | 2 | 0 | 4 | Jan 5, 2023 | Director |
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Jan 3, 2023 | 2 | 129,293 | 4 | Jan 4, 2023 | Director |
CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Dec 5, 2022 | 0 | 0 | 3 | Dec 14, 2022 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Oct 3, 2022 | 2 | 0 | 4 | Oct 5, 2022 | Director |
REGN | REGENERON PHARMACEUTICALS, INC. | Oct 3, 2022 | 0 | 0 | 3 | Oct 5, 2022 | Director |